Podcast Episodes
Back to Search
223: Fauci's non-retirement, grading biotech VCs, & a bellwether IPO
Our colleague Helen Branswell joins to explain the Covid-19 booster debate, the Biden Administration’s monkeypox response, and the long career of the…
4 years, 2 months ago
222: Private equity in autism care, a watershed FDA approval, & the future of ALS treatment
First, STAT's Tara Bannow joins us to discuss how private equity's mounting interest in autism care has created an untenable situation for many paren…
4 years, 2 months ago
221: Big egos in Big Science, the return of Merger Monday, & the fallout over drug pricing
Are biotech's fortunes finally changing? Is Big Science impeding actual science? And what will Medicare negotiation mean for drug prices? STAT's Jaso…
4 years, 2 months ago
220: The last-minute push for drug pricing reform, Alnylam's success, and Sarepta's gamble
Is drug pricing reform really happening this time? Are things finally turning around for biotech? And is it ever wise to tweet your food? Rachel Cohr…
4 years, 2 months ago
219: Helen Branswell on monkeypox, plus: an FDA controversy and fake Alzheimer's data
Can monkeypox be contained? Are snortable Covid-19 vaccines on the way? And when is a GIF worth $200,000? STAT's Helen Branswell joins us to explain …
4 years, 3 months ago
218: Well-paid CEOs, behind the scenes at Moderna, & Biogen's CEO search
Does any CEO deserve $500 million a year? How did Moderna hit it big? And who wants to run Biogen? STAT's Bob Herman joins us to explain why health c…
4 years, 3 months ago
217: CRISPR for the heart, biotech's recovery, & what it means to be a 'hot girl'
Can CRISPR edit out a heart attack? What happens on #GutTok? And is health care recession-proof? Sek Kathiresan, cardiologist and CEO of Verve Therap…
4 years, 3 months ago
216: VC malaise, FDA confusion, & yet another Alzheimer's debate
Is the era of the unicorn over? What's gotten into the FDA? And will a NASH drug ever work? Our colleague Allison DeAngelis joins us to explain how t…
4 years, 3 months ago
215: Medical privacy post-Roe, fixing clinical trials, & the next Covid vaccines
How do you stop a Covid surge? Why are clinical trials so white? And what are the limits of HIPAA? Our colleague Eric Boodman joins us to discuss whe…
4 years, 4 months ago
214: Juul's doomsday, Merck's buyout plans, & the next Theranos verdict
Just how powerful is the FDA? Is Merck about to spend $40 billion? And what's a "Puff Bar"? STAT Washington correspondent Nicholas Florko joins us to…
4 years, 4 months ago